{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T08:28:45Z","timestamp":1774600125502,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s11908-013-0389-2","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T08:44:19Z","timestamp":1389257059000},"source":"Crossref","is-referenced-by-count":33,"title":["Urinary Tract Infection in Diabetes: Epidemiologic Considerations"],"prefix":"10.1007","volume":"16","author":[{"given":"Victoire","family":"de Lastours","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betsy","family":"Foxman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"389_CR1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5414\/CN107216","volume":"77","author":"R Funfstuck","year":"2012","unstructured":"Funfstuck R, Nicolle LE, Hanefeld M, Naber KG. Urinary tract infection in patients with diabetes mellitus. Clin Nephrol. 2012;77:40\u20138.","journal-title":"Clin Nephrol"},{"key":"389_CR2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00001432-200502000-00009","volume":"18","author":"LE Nicolle","year":"2005","unstructured":"Nicolle LE. Urinary tract infection in diabetes. Curr Opin Infect Dis. 2005;18:49\u201353.","journal-title":"Curr Opin Infect Dis"},{"key":"389_CR3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/cid\/cit441","volume":"57","author":"EJ Baron","year":"2013","unstructured":"Baron EJ, Miller JM, Weinstein MP, et al. Executive summary: a guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis. 2013;57:485\u20138.","journal-title":"Clin Infect Dis"},{"key":"389_CR4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2337\/dc10-0421","volume":"34","author":"M Renko","year":"2011","unstructured":"Renko M, Tapanainen P, Tossavainen P, Pokka T, Uhari M. Meta-analysis of the significance of asymptomatic bacteriuria in diabetes. Diabetes Care. 2011;34:230\u20135.","journal-title":"Diabetes Care"},{"key":"389_CR5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00345-005-0042-2","volume":"24","author":"LE Nicolle","year":"2006","unstructured":"Nicolle LE, Zhanel GG, Harding GK. Microbiological outcomes in women with diabetes and untreated asymptomatic bacteriuria. World J Urol. 2006;24:61\u20135.","journal-title":"World J Urol"},{"key":"389_CR6","first-page":"985","volume":"74","author":"R Colgan","year":"2006","unstructured":"Colgan R, Nicolle LE, McGlone A, Hooton TM. Asymptomatic bacteriuria in adults. Am Fam Physician. 2006;74:985\u201390.","journal-title":"Am Fam Physician"},{"key":"389_CR7","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa021042","volume":"347","author":"GK Harding","year":"2002","unstructured":"Harding GK, Zhanel GG, Nicolle LE, Cheang M. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med. 2002;347:1576\u201383.","journal-title":"N Engl J Med"},{"key":"389_CR8","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1001\/archinte.166.20.2222","volume":"166","author":"R Meiland","year":"2006","unstructured":"Meiland R, Geerlings SE, Stolk RP, Netten PM, Schneeberger PM, Hoepelman AI. Asymptomatic bacteriuria in women with diabetes mellitus: effect on renal function after 6 years of follow-up. Arch Intern Med. 2006;166:2222\u20137.","journal-title":"Arch Intern Med"},{"key":"389_CR9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1086\/427507","volume":"40","author":"LE Nicolle","year":"2005","unstructured":"Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005;40:643\u201354.","journal-title":"Clin Infect Dis"},{"key":"389_CR10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1086\/600883","volume":"49","author":"S Dalal","year":"2009","unstructured":"Dalal S, Nicolle L, Marrs CF, Zhang L, Harding G, Foxman B. Long-term Escherichia coli asymptomatic bacteriuria among women with diabetes mellitus. Clin Infect Dis. 2009;49:491\u20137.","journal-title":"Clin Infect Dis"},{"key":"389_CR11","doi-asserted-by":"crossref","unstructured":"Sanden AK, Johansen MB, Pedersen L, Lervang HH, Schonheyder HC, Thomsen RW. Change from oral antidiabetic therapy to insulin and risk of urinary tract infections in Type 2 diabetic patients: a population-based prescription study. J Diabetes Complicat. 2010;24:375\u201381. This large population-based study demonstrates that glycemic control is not associated with UTI risk.","DOI":"10.1016\/j.jdiacomp.2010.01.002"},{"key":"389_CR12","doi-asserted-by":"crossref","unstructured":"Lin TL, Chen GD, Chen YC, Huang CN, Ng SC. Aging and recurrent urinary tract infections are associated with bladder dysfunction in type 2 diabetes. Taiwan J Obstet Gynecol. 2012;51:381\u20136. This prospective study presents results of urodynamic studies among 181 women with type 2 diabetes and lower bladder dysfunction.","DOI":"10.1016\/j.tjog.2012.07.011"},{"key":"389_CR13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/431587","volume":"41","author":"LM Muller","year":"2005","unstructured":"Muller LM, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005;41:281\u20138.","journal-title":"Clin Infect Dis"},{"key":"389_CR14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00125-006-0570-3","volume":"50","author":"T Benfield","year":"2007","unstructured":"Benfield T, Jensen JS, Nordestgaard BG. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia. 2007;50:549\u201354.","journal-title":"Diabetologia"},{"key":"389_CR15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7326\/0003-4819-142-1-200501040-00008","volume":"142","author":"D Scholes","year":"2005","unstructured":"Scholes D, Hooton TM, Roberts PL, Gupta K, Stapleton AE, Stamm WE. Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med. 2005;142:20\u20137.","journal-title":"Ann Intern Med"},{"key":"389_CR16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/oxfordjournals.aje.a000181","volume":"161","author":"EJ Boyko","year":"2005","unstructured":"Boyko EJ, Fihn SD, Scholes D, Abraham L, Monsey B. Risk of urinary tract infection and asymptomatic bacteriuria among diabetic and nondiabetic postmenopausal women. Am J Epidemiol. 2005;161:557\u201364.","journal-title":"Am J Epidemiol"},{"key":"389_CR17","doi-asserted-by":"crossref","unstructured":"Hirji I, Guo Z, Andersson SW, Hammar N, Gomez-Caminero A. Incidence of urinary tract infection among patients with type 2 diabetes in the UK General Practice Research Database (GPRD). J Diabetes Complications. 2012;26:513\u20136. This study estimates the incidence of UTI among person with and without type 2 diabetes by age and gender using 17 years of data from the UK General Practice Research Database.","DOI":"10.1016\/j.jdiacomp.2012.06.008"},{"key":"389_CR18","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/pds.2043","volume":"19","author":"N Hammar","year":"2010","unstructured":"Hammar N, Farahmand B, Gran M, Joelson S, Andersson SW. Incidence of urinary tract infection in patients with type 2 diabetes. Experience from adverse event reporting in clinical trials. Pharmacoepidemiol Drug Saf. 2010;19:1287\u201392.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"389_CR19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.juro.2008.03.044","volume":"180","author":"JC Truzzi","year":"2008","unstructured":"Truzzi JC, Almeida FM, Nunes EC, Sadi MV. Residual urinary volume and urinary tract infection\u2013when are they linked? J Urol. 2008;180:182\u20135.","journal-title":"J Urol"},{"key":"389_CR20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/2013.jamainternmed.829","volume":"173","author":"DM Drekonja","year":"2013","unstructured":"Drekonja DM, Rector TS, Cutting A, Johnson JR. Urinary tract infection in male veterans: treatment patterns and outcomes. JAMA Intern Med. 2013;173:62\u20138.","journal-title":"JAMA Intern Med"},{"key":"389_CR21","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.juro.2008.11.021","volume":"181","author":"CA Czaja","year":"2009","unstructured":"Czaja CA, Rutledge BN, Cleary PA, Chan K, Stapleton AE, Stamm WE. Urinary tract infections in women with type 1 diabetes mellitus: survey of female participants in the epidemiology of diabetes interventions and complications study cohort. J Urol. 2009;181:1129\u201334. discussion 1134\u20135.","journal-title":"J Urol"},{"key":"389_CR22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jmii.2011.12.024","volume":"46","author":"MC Wang","year":"2013","unstructured":"Wang MC, Tseng CC, Wu AB, et al. Bacterial characteristics and glycemic control in diabetic patients with Escherichia coli urinary tract infection. J Microbiol Immunol Infect. 2013;46:24\u20139.","journal-title":"J Microbiol Immunol Infect"},{"key":"389_CR23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/fampra\/cmq026","volume":"27","author":"KJ Gorter","year":"2010","unstructured":"Gorter KJ, Hak E, Zuithoff NP, Hoepelman AI, Rutten GE. Risk of recurrent acute lower urinary tract infections and prescription pattern of antibiotics in women with and without diabetes in primary care. Fam Pract. 2010;27:379\u201385.","journal-title":"Fam Pract"},{"key":"389_CR24","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.2337\/dc07-2188","volume":"31","author":"C Schneeberger","year":"2008","unstructured":"Schneeberger C, Stolk RP, Devries JH, Schneeberger PM, Herings RM, Geerlings SE. Differences in the pattern of antibiotic prescription profile and recurrence rate for possible urinary tract infections in women with and without diabetes. Diabetes Care. 2008;31:1380\u20135.","journal-title":"Diabetes Care"},{"key":"389_CR25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1464-410X.2006.06222.x","volume":"98","author":"PE Pertel","year":"2006","unstructured":"Pertel PE, Haverstock D. Risk factors for a poor outcome after therapy for acute pyelonephritis. BJU Int. 2006;98:141\u20137.","journal-title":"BJU Int"},{"key":"389_CR26","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1111\/j.1532-5415.2009.02550.x","volume":"57","author":"DP Kofteridis","year":"2009","unstructured":"Kofteridis DP, Papadimitraki E, Mantadakis E, et al. Effect of diabetes mellitus on the clinical and microbiological features of hospitalized elderly patients with acute pyelonephritis. J Am Geriatr Soc. 2009;57:2125\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"389_CR27","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1464-5491.2004.01169.x","volume":"21","author":"R Meiland","year":"2004","unstructured":"Meiland R, Geerlings SE, De Neeling AJ, Hoepelman AI. Diabetes mellitus in itself is not a risk factor for antibiotic resistance in Escherichia coli isolated from patients with bacteriuria. Diabet Med. 2004;21:1032\u20134.","journal-title":"Diabet Med"},{"key":"389_CR28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2334-6-54","volume":"6","author":"M Bonadio","year":"2006","unstructured":"Bonadio M, Costarelli S, Morelli G, Tartaglia T. The influence of diabetes mellitus on the spectrum of uropathogens and the antimicrobial resistance in elderly adult patients with urinary tract infection. BMC Infect Dis. 2006;6:54.","journal-title":"BMC Infect Dis"},{"key":"389_CR29","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/j.diabres.2009.04.020","volume":"85","author":"A Papazafiropoulou","year":"2009","unstructured":"Papazafiropoulou A, Daniil I, Sotiropoulos A, et al. Urinary tract infection, uropathogens and antimicrobial resistance in diabetic and nondiabetic patients. Diabetes Res Clin Pract. 2009;85:e12\u20133.","journal-title":"Diabetes Res Clin Pract"},{"key":"389_CR30","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/cid\/cis942","volume":"56","author":"Y Doi","year":"2013","unstructured":"Doi Y, Park YS, Rivera JI, et al. Community-associated extended-spectrum beta-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis. 2013;56:641\u20138.","journal-title":"Clin Infect Dis"},{"key":"389_CR31","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/cid\/cis947","volume":"56","author":"B Foxman","year":"2013","unstructured":"Foxman B. Editorial commentary: extended-spectrum beta-lactamase-producing escherichia coli in the united states: time to rethink empirical treatment for suspected E. coli infections? Clin Infect Dis. 2013;56:649\u201351.","journal-title":"Clin Infect Dis"},{"key":"389_CR32","doi-asserted-by":"crossref","first-page":"e69581","DOI":"10.1371\/journal.pone.0069581","volume":"8","author":"A Soraas","year":"2013","unstructured":"Soraas A, Sundsfjord A, Sandven I, Brunborg C, Jenum PA. Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae\u2013a case\u2013control study in a low prevalence country. PLoS One. 2013;8:e69581.","journal-title":"PLoS One"},{"key":"389_CR33","doi-asserted-by":"crossref","first-page":"e30498","DOI":"10.1371\/journal.pone.0030498","volume":"7","author":"MH Nicolas-Chanoine","year":"2012","unstructured":"Nicolas-Chanoine MH, Jarlier V, Robert J, et al. Patient's origin and lifestyle associated with CTX-M-producing Escherichia coli: a case\u2013control-control study. PLoS One. 2012;7:e30498.","journal-title":"PLoS One"},{"key":"389_CR34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1517\/14728214.2013.831405","volume":"18","author":"LD Boyle","year":"2013","unstructured":"Boyle LD, Wilding JP. Emerging sodium\/glucose co-transporter 2 inhibitors for type 2 diabetes. Expert Opin Emerg Drugs. 2013;18:375\u201391.","journal-title":"Expert Opin Emerg Drugs"},{"key":"389_CR35","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0140-6736(13)60683-2","volume":"382","author":"WT Cefalu","year":"2013","unstructured":"Cefalu WT, Leiter LA, Yoon KH, et al. Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial. Lancet. 2013;382:941\u201350.","journal-title":"Lancet"},{"key":"389_CR36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/dom.12090","volume":"15","author":"JF Yale","year":"2013","unstructured":"Yale JF, Bakris G, Cariou B, et al. Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease. Diabetes Obes Metab. 2013;15:463\u201373.","journal-title":"Diabetes Obes Metab"},{"key":"389_CR37","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/dom.12054","volume":"15","author":"K Stenlof","year":"2013","unstructured":"Stenlof K, Cefalu WT, Kim KA, et al. Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise. Diabetes Obes Metab. 2013;15:372\u201382.","journal-title":"Diabetes Obes Metab"},{"key":"389_CR38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","volume":"378","author":"G Danaei","year":"2011","unstructured":"Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31\u201340.","journal-title":"Lancet"},{"key":"389_CR39","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s11908-013-0317-5","volume":"15","author":"B Foxman","year":"2013","unstructured":"Foxman B, Buxton M. Alternative approaches to conventional treatment of acute uncomplicated urinary tract infection in women. Curr Infect Dis Rep. 2013;15:124\u20139.","journal-title":"Curr Infect Dis Rep"},{"key":"389_CR40","doi-asserted-by":"crossref","unstructured":"Johnsson KM, Ptaszynska A, Schmitz B, Sugg J, Parikh SJ, List JF. Urinary tract infections in patients with diabetes treated with dapagliflozin. J Diabetes Complications. 2013;27:473\u20138. This meta analysis of safety data from 12 clinical trials, assessed the increased risk of UTI with treatment with dapagliflozin.","DOI":"10.1016\/j.jdiacomp.2013.05.004"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-013-0389-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-013-0389-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-013-0389-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T02:30:45Z","timestamp":1565058645000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-013-0389-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["389"],"URL":"https:\/\/doi.org\/10.1007\/s11908-013-0389-2","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1]]},"article-number":"389"}}